CICC International: Raises Target Price of WuXi AppTec (02359.HK) to 131 Hong Kong Dollars, Maintains "Outperform" Rating

According to the Wise Finance APP, BOCI Research report stated that it has raised the target price of WuXi AppTec (02359.HK) by 7.4%, from 122 Hong Kong dollars to 131 Hong Kong dollars, maintaining an "outperform" rating. The bank mentioned that despite the potential implementation of the "U.S. Biosecurity Act 2.0", the company continues to expand its drug range while also serving clients for GLP-1 targeted drugs. The bank forecasted that the company's performance in the third quarter of 2025 will exceed expectations, with net profit increasing from 23 billion RMB in the same period in 2024 to 35 billion RMB, and total revenue growing by 15% year-on-year to 121 billion RMB.